A Study for Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This drug is being evaluated for possible treatment of type 2 diabetes mellitus.
Participation in this study is expected to last up to 18 weeks. A goal of this study is to
determine the safety and effectiveness of LY2409021.